SOURCE: Blue Stream Laboratories

Blue Stream Laboratories

November 04, 2015 10:01 ET

Blue Stream Laboratories Adds Capacity to Accommodate Continued Growth in Biosimilars

Will Exhibit at Booth 8 at Well Characterized Biologicals, Nov. 9-10 in Reston, VA

WOBURN, MA--(Marketwired - Nov 4, 2015) - Blue Stream Laboratories, an advanced analytical laboratory specializing in recombinant glycoprotein and complex biologics characterization services, is expanding into new office and lab space, adjacent to its current facility, to handle the continued growth of its biosimilars services. Last year, the company moved into new space in Woburn to double the capacity of its prior Cambridge facility.

Blue Stream will exhibit at Booth 8 at the Well Characterized Biologicals Conference from Nov. 9-10 at the Hyatt Regency Reston VA.

Having provided characterization services for 10 of the top biosimilar products in development, Blue Stream offers a complete suite of analytical solutions for biosimilar product development from initial product screening to biosimilar/originator comparability to comprehensive characterization including primary and secondary/tertiary structure, glycosylation/PTMs, and activity.

The biosimilar segment continues to perform well for the company. In 2014, Blue Stream recorded a 60 percent increase in revenue over the prior year, along with a 50 percent increase in facility size, and a 30 percent expansion of its research and development capabilities. This growth was significantly driven by Blue Stream's biosimilars services.

"The market for biosimilars continues to grow, with consensus of reaching at least $20 billion within the next few years. Blue Stream has significant biosimilar expertise, and we continue to invest in the people, equipment and infrastructure to develop innovative methods, improve quality and extend our expertise," said William Rash, VP, Sales and Marketing of Blue Stream Laboratories. 

About Blue Stream Laboratories
Blue Stream Laboratories is an advanced analytical laboratory specializing in recombinant glycoprotein and complex biologics characterization services. Blue Stream supports Pre-IND through cGMP clinical phase product development programs for product characterization, cGMP lot release, and stability program support. Located 10 miles outside of Boston, and serving companies throughout the U.S. and overseas, Blue Stream's clients range from small start-ups and virtual biotechs to Fortune 500 pharmaceutical and medical device companies. For more information, please visit the company website at www.bluestreamlabs.com.

Contact Information

  • Media Contact:
    Norman Birnbach
    Birnbach Communications
    781-639-6701
    Email Contact